Search PDMR transactions

Notifier
Name of person with notification obligation
Sofia Heigis
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Sofia Heigis
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Oncopeptides AB
Issuer´s LEI code
549300J9WWQ5CBYQ1M77
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Subscription right/Unit right Oncopeptides AB TR SE0021924362 Acquisition 30,000 Quantity 0.137 SEK 25/04/2024 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Oncopeptides AB TR SE0021924362 Acquisition 25/04/2024 NASDAQ STOCKHOLM AB 30,000 (Quantity) 0.137 SEK
<< Back